Doctor profile · Federal record
Dr. DANNY BARLEV, M.D
Dermatology Physician (CMS: DERMATOLOGY) · Student in an Organized Health Care Education/Training Program · CLEVELAND, OH
- NPI 1285991372
- Accepts Medicare
- MIPS 79.5 / 100 · 2023
- 14 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
11100 EUCLID AVE
CLEVELAND, OH 441061716
(650) 504-9860 - Additional location
-
2301 Holmes St, Truman Medical Center, Hospital Hill
Kansas City, MO 641082640
(816) 404-4175
fax (816) 404-0003
Credentials & registration
- NPI registered
- April 2012 — 14 yrs on file
- Profile last updated
- January 12, 2021
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #35.133853
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285991372. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,476
Distinct HCPCS
10
Medicare allowed
$86,963
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 544 | 83 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 297 | 217 | $87 | |
11102 |
Biopsy of related skin growth, first growth | 144 | 124 | $91 | |
17000 |
Destruction of precancer skin growth, 1 growth | 144 | 108 | $47 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 70 | 57 | $124 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 69 | 69 | $107 | |
11103 |
Biopsy of related skin growth, each additional growth | 55 | 40 | $47 | |
17110 |
Destruction of skin growth, 1-14 growths | 42 | 36 | $108 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 31 | 26 | $54 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 27 | 27 | $162 |
In context: peer comparison
Among 26 peers in this city , average services per provider: 95. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$42
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 1 | $26.93 | |
| Arcutis Biotherapeutics, Inc. | 1 | $15.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
709
Patients
329
Total drug cost
$988,302
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 129 | 73 | $2,274 |
| Clobetasol Propionate | Generic | 112 | 65 | $12,477 |
| Ketoconazole | Generic | 105 | 61 | $3,153 |
| Fluocinonide | Generic | 56 | 33 | $3,651 |
| Hydrocortisone | Generic | 41 | 23 | $609 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 39 | 0 | $313,821 |
| Tacrolimus | Generic | 39 | 23 | $9,200 |
| Clindamycin Phosphate | Generic | 33 | 12 | $2,022 |
| Humira(Cf) Pen (Adalimumab) | Brand | 31 | 0 | $413,542 |
| Dupixent Pen (Dupilumab) | Brand | 27 | 0 | $103,020 |